Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

192
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
192
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

82
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
82
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The efficient stored specimen design for evaluating multiple screening technologies: Application to multicancer detection tests.

Journal of medical screening·2025
Same author

The Role of the Extracellular Matrix in Cancer Prevention.

Cancers·2025
Same author

Prediagnostic evaluation of multicancer detection tests: design and analysis considerations.

Journal of the National Cancer Institute·2024
Same author

Evaluating Risk Prediction with Data Collection Costs: Novel Estimation of Test Tradeoff Curves.

Medical decision making : an international journal of the Society for Medical Decision Making·2023
Same author

Metrics for Evaluating Polygenic Risk Scores.

JNCI cancer spectrum·2021
Same author

Modeling the mean time to interval cancer after negative results of periodic cancer screening.

Statistics in medicine·2020
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
查看所有相关文章

相关实验视频

Updated: Jun 6, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

218

多种癌症检测测试的量化过度诊断:一种新的方法方法.

Stuart G Baker1

  • 1Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.

Statistics in medicine
|November 26, 2024
PubMed
概括
此摘要是机器生成的。

在多种癌症检测 (MCD) 测试中量化过度诊断至关重要. 一种新方法使用每年的MCD测试估计了查过度诊断分数 (SOF),解决了人们对早期癌症检测不必要的治疗的担忧.

关键词:
癌症查 癌症查领先时间 领先时间多种癌症早期检测试验过度诊断是一种过度诊断

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

360

相关实验视频

Last Updated: Jun 6, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

218
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

360

科学领域:

  • 在瘤学瘤学.
  • 生物统计学 生物统计学
  • 医学查 医学查

背景情况:

  • 多种癌症检测 (MCD) 测试从血液样本中识别出临床前癌症.
  • 过度诊断,检测不会出现症状的癌症,是查的一个重要问题,可能导致有害的治疗.
  • 量化过度诊断,特别是屏幕过度诊断分数 (SOF),是必不可少的,但具有挑战性,特别是对于快速发展的MCD技术.

研究的目的:

  • 引入一种新的方法来估计用于多种癌症检测 (MCD) 查程序的平均查超诊断分数 (SOF).
  • 解决SOF估计的困难,因为过度诊断的未观察到的性质和需要MCD测试的短期数据.
  • 开发一种在没有传统查的情况下适用于癌症的方法,并且适应技术变化.

主要方法:

  • 提出了一种新方法,要求在不同年龄段的个人中每年至少进行两次MCD测试.
  • 该方法假设在操作临床前癌症 (OPC) 状态下停留时间的指数分布.
  • 创建一个SOF图表,将平均SOF与平均逗留时间进行图形化,使用肺癌查和合成数据.

主要成果:

  • 拟议的SOF图表方法证明了区分SOF的小到中等水平的能力.
  • 该方法仅依赖于一个与指数分布假设的项,使其结果对违规行为具有稳定性.
  • 这项研究为估计SOF提供了一个新的工具,对于MCD测试特别有价值,因为短期数据可用.

结论:

  • 新的SOF图形方法为估计MCD查中的过度诊断提供了对现有模型的补充方法.
  • 这种方法对于评估MCD测试等新查技术中过度诊断的风险特别有用.
  • 建议进一步应用SOF图,因为MCD测试的短期观察数据越来越多.